IN-VITRO STUDY OF Α- GLUCOSIDASE INHIBITION ACTIVITY OF ALSTONIA SCHOLARIS AND CATHARANTHUS ROSEUS

Authors

  • Khushali Thaker
  • Jaimini Patoliya
  • Khushbu Rabadiya
  • Zankruti Dholakia
  • Rushikesh Joshi Gujarat University

DOI:

https://doi.org/10.47413/vidya.v1i2.45

Keywords:

Type 2 diabetes mellitus,, α- glucosidase inhibitors, Alstonia scholaris, Catharanthus roseus, Plant extracts

Abstract

The increasing population of Diabetes Mellitus (DM) in the world has always been concerned by physicians and scientists due to its life-threatening effects including heart diseases and premature death. Out of them, nearly 90-95% population is having type 2 diabetes mellitus (T2DM), characterised by insulin resistance. The available treatments for T2DM includes inhibition of α- glucosidase present on the brush border of human intestine that controls post-prandial hyperglycaemia by slower the releasing of glucose in the blood. Adverse effects of the available α- glucosidase inhibitors (AGI) such as abdominal discomfort and hypoglycaemia has prompted a search for the newer AGIs from natural compounds. The impact of various plant extracts on the management of medical disorders has recently aroused curiosity of researchers. Alstonia scholaris has set its hight reputation in ethnopharmacological world for treating major health issues including skin carcinoma, lung cancer and also T2DM. Though some research supports the antidiabetic activity of the plant, the mode of action responsible for it has yet to be discovered. At the same time, Catharanthus roseus has also been proved to be effective in diabetic conditions but in vitro study of antidiabetic activity of the plant is yet to be encountered. The presented study investigated different extracts of A. scholaris and C. roseus on α- glucosidase isolated from Saccharomyces cerevisiae. The presented research  not only gives in-vitro proves of the plants as AGIs but also open ups new pathways in understanding the secondary metabolites as inhibitors.

References

Ajanal, Manjunath, MahadevB Gundkalle, and ShraddaU Nayak. 2012. “Estimation of Total Alkaloid in Chitrakadivati by UV-Spectrophotometer.” Ancient Science of Life 31(4):198. doi: 10.4103/0257-7941.107361.

Alkreathy, Huda Mohammed, and Aftab Ahmad. 2020. “Catharanthus Roseus Combined with Ursolic Acid Attenuates Streptozotocin-Induced Diabetes through Insulin Secretion and Glycogen Storage.” Oxidative Medicine and Cellular Longevity 2020. doi: 10.1155/2020/8565760.

Arulmozhi, Sinnathambi, Papiya Mitra Mazumder, Sathiyanarayanan Lohidasan, and Prasad Thakurdesai. 2010. “Antidiabetic and Antihyperlipidemic Activity of Leaves of Alstonia Scholaris Linn. R.Br.” European Journal of Integrative Medicine 2(1):23–32. doi: 10.1016/j.eujim.2009.12.001.

Bayraktar, Miyase, David H. Van Thiel, and Nezaket Adalar. 1996. “A Comparison of Acarbose versus Metformin as an Adjuvant Therapy in Sulfonylurea-Treated NIDDMI Patients.” Diabetes Care 19(3):252–54. doi: 10.2337/diacare.19.3.252.

Cho, N. H., J. E. Shaw, S. Karuranga, Y. Huang, J. D. da Rocha Fernandes, A. W. Ohlrogge, and B. Malanda. 2018. “IDF Diabetes Atlas: Global Estimates of Diabetes Prevalence for 2017 and Projections for 2045.” Diabetes Research and Clinical Practice 138:271–81. doi: 10.1016/j.diabres.2018.02.023.

Chougale, Ashok D., Varsha A. Ghadyale, Shrimant N. Panaskar, and Akalpita U. Arvindekar. 2009. “Alpha Glucosidase Inhibition by Stem Extract of Tinospora Cordifolia.” Journal of Enzyme Inhibition and Medicinal Chemistry 24(4):998–1001. doi: 10.1080/14756360802565346.

Coniff, Robert F., Jo Ann Shapiro, Timothy B. Seaton, and George A. Bray. 1995. “Multicenter, Placebo-Controlled Trial Comparing Acarbose (BAY g 5421) with Placebo, Tolbutamide, and Tolbutamide-plus-Acarbose in Non-Insulin-Dependent Diabetes Mellitus.” The American Journal of Medicine 98(5):443–51. doi: 10.1016/S0002-9343(99)80343-X.

Halvorson. 1957. “Saccharomyces i t a l i c u S.” BIOCHIMICA ET BIOPHYSICA ACTA 3.

He, Ming, Yuhan Zhai, Yuqing Zhang, Shuo Xu, Shaoxuan Yu, Yingxin Wei, Haifang Xiao, and Yuanda Song. 2022. “Inhibition of α-Glucosidase by Trilobatin and Its Mechanism: Kinetics, Interaction Mechanism and Molecular Docking.” Food & Function 13(2):857–66. doi: 10.1039/D1FO03636J.

Jagetia, Ganesh Chandra, and Manjeshwar Shrinath Baliga. 2006. “Evaluation of Anticancer Activity of the Alkaloid Fraction of Alstonia Scholaris (Sapthaparna) in Vitro and in Vivo.” Phytotherapy Research 20(2):103–9. doi: 10.1002/ptr.1810.

Jahan, Swafiya, Ranu Chaudhary, and Pradeep Kumar Goyal. 2009. “Anticancer Activity of an Indian Medicinal Plant, Alstonia Scholaris, on Skin Carcinogenesis in Mice.” Integrative Cancer Therapies 8(3):273–79. doi: 10.1177/1534735409343590.

Jong-Anurakkun, Nilubon, Megh Raj Bhandari, and Jun Kawabata. 2007. “α-Glucosidase Inhibitors from Devil Tree (Alstonia Scholaris).” Food Chemistry 103(4):1319–23. doi: 10.1016/j.foodchem.2006.10.043.

Kala, Chandra Parakash. 2005. “Ethnomedicinal Botany of the Apatani in the Eastern Himalayan Region of India.” Journal of Ethnobiology and Ethnomedicine 1:1–8. doi: 10.1186/1746-4269-1-11.

Khan, J. B., and G. P. Singh. 1970. “Ethno-Medicinal Active Plants for Treating Cold and Cough in the Vicinity of Nahargarh Wildlife Sanctuary, Jaipur, India.” Our Nature 8(1):225–30. doi: 10.3126/on.v8i1.4332.

Khyade, Mahendra S., Deepak M. Kasote, and Nityanand P. Vaikos. 2014. “Alstonia Scholaris (L.) R. Br. and Alstonia Macrophylla Wall. Ex G. Don: A Comparative Review on Traditional Uses, Phytochemistry and Pharmacology.” Journal of Ethnopharmacology 153(1):1–18. doi: 10.1016/j.jep.2014.01.025.

Mangiagli, Antonino, Salvatore Italia, Vincenzo De Sanctis, and Saveria Campisi. 2002. “Impaired Glucose Homeostasis in Young Adult Thalassemic Patients: A Pilot Study with Acarbose.” Journal of Pediatric Endocrinology and Metabolism 15(2):205–10. doi: 10.1515/JPEM.2002.15.2.205.

Martin, Anne E., and Patricia A. Montgomery. 1996. “Acarbose: An a-Glucosidase Inhibitor.” 53(X):2277–90.

Oguntibeju, Oluwafemi, Yapo Aboua, and Mediline Goboza. 2019. “Vindoline—A Natural Product from Catharanthus Roseus Reduces Hyperlipidemia and Renal Pathophysiology in Experimental Type 2 Diabetes.” Biomedicines 7(3):59. doi: 10.3390/biomedicines7030059.

Omara, Timothy, Ambrose K. Kiprop, Rose C. Ramkat, Jackson Cherutoi, Sarah Kagoya, Decrah Moraa Nyangena, Tsedey Azeze Tebo, Papias Nteziyaremye, Lucy Nyambura Karanja, Abigael Jepchirchir, Alfayo Maiyo, Betty Jematia Kiptui, Immaculate Mbabazi, Caroline Kiwanuka Nakiguli, Brenda Victoria Nakabuye, and Margaret Chepkemoi Koske. 2020. “Medicinal Plants Used in Traditional Management of Cancer in Uganda: A Review of Ethnobotanical Surveys, Phytochemistry, and Anticancer Studies.” Evidence-Based Complementary and Alternative Medicine 2020. doi: 10.1155/2020/3529081.

Rai, Vartika, Pramod Kumar Tandon, and Sayyada Khatoon. 2014. “Effect of Chromium on Antioxidant Potential of Catharanthus Roseus Varieties and Production of Their Anticancer Alkaloids: Vincristine and Vinblastine.” BioMed Research International 2014. doi: 10.1155/2014/934182.

Reza, Md Sharif, Md Sadikur Rahman Shuvo, Md Mahadi Hassan, Mohammad Anwarul Basher, Md Amirul Islam, Nura Ershad Naznin, Sarah Jafrin, Khondoker Shahin Ahmed, Hemayet Hossain, and A. F. M. Shahi. Ud Daula. 2020. “Antidiabetic and Hepatoprotective Potential of Whole Plant Extract and Isolated Compounds of Aeginetia Indica.” Biomedicine and Pharmacotherapy 132:110942. doi: 10.1016/j.biopha.2020.110942.

Sajem, Albert L., Jayashree Rout, and Minaram Nath. 2008. “Traditional Tribal Knowledge and Status of Some Rare and Endemic Medicinal Plants of North Cachar Hills District of Assam, Northeast India.” Ethnobotanical Leaflets 12:261–75.

Shanmugam, S., K. Rajendran, and M. Annadurai. 2011. “Ethnomedicinal Plants Used to Cure Diarrhoea and Dysentery in Pachalur Hills of Dindigul District in Tamil Nadu, Southern India.” Journal of Applied Pharmaceutical Science 1(8):94–97.

Sharma, Priyanka, Tushar Joshi, Tanuja Joshi, Subhash Chandra, and Sushma Tamta. 2020. “In Silico Screening of Potential Antidiabetic Phytochemicals from Phyllanthus Emblica against Therapeutic Targets of Type 2 Diabetes.” Journal of Ethnopharmacology 248:112268. doi: 10.1016/j.jep.2019.112268.

Soni, Pranay, Rajesh Choudhary, and Surendra H. Bodakhe. 2019. “Effects of a Novel Isoflavonoid from the Stem Bark of Alstonia Scholaris against Fructose-Induced Experimental Cataract.” Journal of Integrative Medicine 17(5):374–82. doi: 10.1016/j.joim.2019.06.002.

Sultana, Nighat, Muhammad Saleem Qazi, and Mustafa Kamal. 2019. “New Anti-Inflammatory Triterpene Esters and Glycosides from Alstonia Scholaris.” Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry 19(4):370–86. doi: 10.2174/1871523018666190724122406.

Ur. Rehman, Najeeb, Ajmal Khan, Ahmed Al-Harrasi, Hidayat Hussain, Abdul Wadood, Muhammad Riaz, and Zahra Al-Abri. 2018. “New α-Glucosidase Inhibitors from the Resins of Boswellia Species with Structure–Glucosidase Activity and Molecular Docking Studies.” Bioorganic Chemistry 79(April):27–33. doi: 10.1016/j.bioorg.2018.04.020.

Wang, Chao Min, Kuei Lin Yeh, Shang Jie Tsai, Yun Lian Jhan, and Chang Hung Chou. 2017. “Anti-Proliferative Activity of Triterpenoids and Sterols Isolated from Alstonia Scholaris against Non-Small-Cell Lung Carcinoma Cells.” Molecules 22(12):1–13. doi: 10.3390/molecules22122119.

Woisky, Ricardo G., and Antonio Salatino. 1998. “Analysis of Propolis: Some Parameters and Procedures for Chemical Quality Control.” Journal of Apicultural Research 37(2):99–105. doi: 10.1080/00218839.1998.11100961.

Downloads

Published

31-12-2022

How to Cite

Thaker, K., Patoliya, J., Rabadiya, K. ., Dholakia, Z. ., & Joshi, R. (2022). IN-VITRO STUDY OF Α- GLUCOSIDASE INHIBITION ACTIVITY OF ALSTONIA SCHOLARIS AND CATHARANTHUS ROSEUS. VIDYA - A JOURNAL OF GUJARAT UNIVERSITY, 1(2), 88–95. https://doi.org/10.47413/vidya.v1i2.45

Issue

Section

Articles